Tolerability of subcutaneous ofatumumab with long-term exposure in relapsing multiple sclerosis.
Kramer J, Linker R, Paling D, Czaplinski A, Hoffmann O, Yong VW, Barker N, Ross AP, Lucassen E, Gufran M, Hu X, Zielman R, Seifer G, Vermersch P.
Kramer J, et al. Among authors: ross ap.
Mult Scler J Exp Transl Clin. 2023 Oct 10;9(4):20552173231203816. doi: 10.1177/20552173231203816. eCollection 2023 Oct-Dec.
Mult Scler J Exp Transl Clin. 2023.
PMID: 37829441
Free PMC article.